Intense immunosuppression was associated with an increased incidence of post-transplant lymphoproliferative disease Incidence study 06 February 2013 Pages: 5 - 5
Immunoglobulin adverse effects in patients with neurological disorders Incidence study 06 February 2013 Pages: 6 - 6
Risk factors for terbinafine-induced taste loss assessed Clinical study 06 February 2013 Pages: 6 - 6
Thromboembolic events occurred in 10% of patients receiving epirubicin + cyclophosphamide Incidence study 06 February 2013 Pages: 6 - 6